Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leukemia, Myelocytic, Acute
|
247 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.740 | 1.000 | 4 | 2009 | 2016 | ||||||
Astrocytoma
|
51 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.720 | 1.000 | 2 | 2009 | 2014 | ||||||
Glioma
|
283 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.720 | 1.000 | 2 | 2011 | 2012 | ||||||
Colorectal Carcinoma
|
1186 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.710 | 1.000 | 1 | 2014 | 2014 | ||||||
Glioblastoma
|
157 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.710 | 1.000 | 1 | 2011 | 2016 | ||||||
Liver carcinoma
|
769 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.710 | 1.000 | 1 | 2016 | 2017 | ||||||
MYELODYSPLASTIC SYNDROME
|
79 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.710 | 1.000 | 1 | 2012 | 2016 | ||||||
Neoplasms
|
1571 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.060 | 1.000 | 6 | 2009 | 2019 | ||||||
Glioblastoma Multiforme
|
160 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.020 | 1.000 | 2 | 2009 | 2011 | ||||||
Hemangioma
|
9 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.020 | 1.000 | 2 | 2011 | 2013 | ||||||
Li-Fraumeni Syndrome
|
37 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.020 | 1.000 | 2 | 2009 | 2018 | ||||||
Malignant Neoplasms
|
1441 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||
melanoma
|
352 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.020 | 1.000 | 2 | 2010 | 2018 | ||||||
Adult Fibrosarcoma
|
9 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Adult Glioblastoma
|
98 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED
|
10 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Central Nervous System Neoplasms
|
12 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Childhood Astrocytoma
|
39 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Childhood Glioblastoma
|
98 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Childhood Osteosarcoma
|
151 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Chondrosarcoma
|
7 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Clear Cell Hepatocellular Carcinoma
|
1 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Congenital Abnormality
|
73 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Enchondroma
|
13 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Fibrosarcoma
|
9 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 |